Articles On Monash IVF Group (ASX:MVF)

Key points The Monash IVF share price has lifted nearly 6% today It comes after COVID-19 IVF restrictions were lifted in Victoria The company will resume IVF services next week The Monash IVF Group Ltd (ASX: MVF) share price is ri...

Following new health orders in Victoria, Monash IVF Group (MVF) says non-urgent surgery protocols will disrupt some IVF procedures in Melbourne and other major centres The group says patients who plan to commence a stimulated cycle after J...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

MoneyTalks is Stockhead’s regular recap of the stocks, sectors and trends that ASX fund managers and analysts are looking at right now and into 2022. Today we hear from Julian Guido from Perennial Partners‘ Value Smaller Companies Trust whe...

An ASX company sometimes buys back its own shares, as a way to return capital to investors. Such actions are not necessarily received well, according to Allan Gray portfolio manager Dr Suhas Nayak. “Some argue that it shows a lack of growt...

SYDNEY, Dec. 9, 2021 /PRNewswire/ — Irongate Group (ASX: IAP; JSE: IAP) has today announced the acquisition of an industrial business park in Perth, the acquisition of an A-grade office building in Melbourne and a fully underwritten institu...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

ShareCafeMVF – Macquarie rates the stock as Outperform Macquarie raises FY22-4 EPS forecasts by 2% for Monash IVF Group following a 1Q trading update and 1H22 profit guidance which was a 5% beat versus the broker’s forecast. The target pric...

A downbeat week leaned towards a lacklustre conclusion following a mixed finish on Wall Street as investors weighed corporate earnings, lingering rates worries and a seasonal uptick in Covid cases. ASX futures edged up eight points or 0....

Australian shares looked set to start a new week little changed as a recovery in the dollar and declines in key commodities offset gains on Wall Street. ASX futures eased three points or 0.04 per cent, signalling a flat start following F...

History shows that shortly after catastrophic events end, the world experiences a baby boom. “When large mortality events occur including diseases, earthquakes, and wars, birth rates decline and on average, reach a trough some 9 months lat...

In this week's Weekly Insights:-Forecasts Are Falling-Conviction Calls-Research To DownloadBy Rudi Filapek-Vandyck, Editor FNArenaForecasts Are FallingAs if investors didn't already have enough to worry about, earnings forecasts around the...

Brokers are always on the search for ASX share opportunities that may be good ideas to consider. Businesses are regularly updating the market and conditions are changing. Add in that fact that share prices are changing as well and investor...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week The Healthcar...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Today, Wednesday the 25th of August, we are happy to buy Ansell (ASX:ANN), HUB24 Ltd (ASX:HUB), Superloop (ASX:SLC), Aerometrex Limited (ASX:AMX), Monash IVF Group Ltd (ASX:MVF), Virtus Health Ltd (ASX:VRT) and Viva Energy Group (ASX:VEA).

The Monash IVF Group Ltd (ASX: MVF) share price is gaining in intraday trade, up 3% to 99 cents per share. This follows on the release of the reproductive services provider’s results for the 2021 financial year ending 30 June (FY21). Monas...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

There are a small number of ASX shares that many brokers like at the same time. It might indicate that there is an opportunity with these businesses because brokers are constantly on the lookout for ideas. If they all like a company, then...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Fortunately, in this low interest rate environment, there are countless dividend shares for investors to choose from on the Australian share market. But with so many to choose from, it can be hard to decide which ones to buy. To narrow thi...

Summary The S&P/ASX200 declined as much as 0.3% to hit a low of 7,316. Six of the 11 sectors were trading lower, while tech and energy were among top laggards. Shares of Rio Tinto fell over 1% after the global miner raised iron or...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

You might think ASX healthcare shares would be among the most insulated from the digital disruption, but that view doesn’t gel with all experts. In fact, some are predicting that the healthcare sector could be next to be shaken by the digi...

Summary Neurotech International has commenced Phase I/II open-label clinical trial in children having Autism Spectrum Disorder. Multinational pharmaceutical company AFT Pharmaceuticals disclosed the extension of licensing of Maxigesic®...

On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week. Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed belo...

Source: Fox_Ana, Shutterstock Summary Amid uncertainties, investors continue to explore dividend stocks to add an extra layer of safety to their investments. ASX listed companies have been consistent dividend payers and declared divid...

On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week. Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed belo...

ShareCafeVRT – Morgan Stanley rates the stock as Underweight Industry growth is better than Morgan Stanley anticipated and it is likely to be elevated across the balance of the second half FY21 at least. The broker has a preference for Mona...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Source: Enjoy The Life, Shutterstock Summary ASX 200 increased 0.8% on Friday, however it edged lower Monday morning with a decline of almost 33% following the quarterly rebalance announcement. ASX 200 saw 6 new companies being added...

The Monash IVF Group Ltd (ASX: MVF) share price is bucking the market downtrend after it posted its profit results and restarted its dividend payouts. The Monash IVF share price jumped 2% to 79 cents when the S&P/ASX 200 Index (Index:^...

The S&P/ASX 200 Index (ASX: XJO) has failed to follow the lead of US markets and is sinking lower on Monday. In late morning trade the benchmark index is down 0.5% to 6,725.6 points. Four shares that are falling more than most today ar...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the year in a disappointing fashion. The benchmark index is currently down 0.7% to 6,637.7 points. Four shares that are falling more than most today are listed bel...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the shortened week on a positive note. At the time of writing, the benchmark index is up 0.6% to 6,680.9 points. Four shares that have failed to follow the m...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The Monash IVF Group Ltd (ASX: MVF) share price is trading lower following the release of a trading update and its guidance for FY 2021 at its annual general meeting. In afternoon trade the fertility treatment company’s shares are down sli...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Earnings s...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a small gain. At the time of writing the benchmark index is up 0.15% to 6,119.6 points. Four shares that have failed to follow the market higher to...

The Monash IVF Group Ltd (ASX: MVF) share price has fallen lower this morning, down 9.95% at the time of writing to 57 cents. The fall in the Monash IVF share price came after the company released its annual result for the year to 30 June...

Hold onto your hats – it’s ASX reporting season! For investors, ASX reporting season rolls around twice per year. It’s that time of year when companies report their financial results, announce their dividend payments (or lack thereof) and,...